Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Obsidian Therapeutics, Inc.
August 3, 2026
Obsidian Therapeutics, Inc.
Neutral Outlook
Cambridge, MA
51-200 employees
The effect of IRA on our business and the healthcare industry in general is not yet known.
Disease Area:
Oncology
Drug Type:
Biologic
Source
Source
Scroll to Top